← Back
Data updated: Mar 10, 2026
HELSINN
Oncology
HELSINN is a pharmaceutical company focused on Oncology. Key products include VALCHLOR.
2013
Since
1
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs Phase 3: 3 Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2013-08-23
- Latest
- 2020-05-01
- Applications
- 1